Study of molecular mechanism of anti-Parkinson's disease traditional Chinese medicine using model of Caenorhabditis elegans.
- Author:
Xiangming WANG
1
;
Xiaoyan WANG
;
Huili GAO
;
Danqiao WANG
Author Information
1. Medical Experimental Center, China Academy of Chinese Medical Sciences, Beijing 100700, China. xm224@sohu.com
- Publication Type:Journal Article
- MeSH:
Animals;
Antiparkinson Agents;
pharmacology;
Caenorhabditis elegans;
drug effects;
Disease Models, Animal;
Humans;
Medicine, Chinese Traditional;
Parkinson Disease;
etiology
- From:
China Journal of Chinese Materia Medica
2010;35(5):661-663
- CountryChina
- Language:Chinese
-
Abstract:
Parkinson's disease (PD) is a neurodegenerative disorder with a complex, multifactorial aetiology. The brains of patients affected with PD are characterized by a loss of neurons in dopamine neurons in the substantia nigra, decreasing of dopamine secretion, and the deposition of Lewy bodies (LBs) in the cytoplasm of remaining neurons. In China the data show that the incidence of Parkinson's disease increases at least 20 times in recent 20 years, and it makes things worse for the aging society. Developing good anti-PD drugs to improve the patient's quality of life is particularly important. The treatment of PD using traditional Chinese medicine (TCM) has made remarkable effect, while the the molecular mechanisms of it is still not known, while elucidating the molecular mechanism of TCM is the base of better understanding its function. Using genetically modified PD model of Caenorhabditis elegans, which is suitable for molecular mechanism study, to explore the interference mechanism of TCM to PD might be an effective way. This review briefly introduces the research progress on molecular mechanism of PD, and then discusses the idea of using C. elegans to study molecular mechanism of TCM intervention to PD.
